CODARD (Respa Pharmaceuticals)
Welcome to the PulseAid listing for the CODAR drug offered from Respa Pharmaceuticals. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | Respa Pharmaceuticals |
NON-PROPRIETARY NAME: | Codeine Phosphate, Pseudoephedrine Hydrochloride |
SUBSTANCE NAME: | CODEINE PHOSPHATE; PSEUDOEPHEDRINE HYDROCHLORIDE |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | LIQUID |
MARKETING CATEGORY NAME: | OTC MONOGRAPH FINAL |
START MARKETING DATE: | 2011-07-13 |
END MARKETING DATE: | 0000-00-00 |
CODAR D HUMAN OTC DRUG Details:
Item Description | CODAR D from Respa Pharmaceuticals |
LABELER NAME: | Respa Pharmaceuticals |
DEA SCHEDULE: | CV
|
ACTIVE STRENGTH: | 8; 30(mg/5mL; mg/5mL) |
START MARKETING DATE: | 2011-07-13 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 60575-515_076f7810-5c2b-4d9b-9a69-4308cb9440ca |
PRODUCT NDC: | 60575-515 |
APPLICATION NUMBER: | part341 |
Other CODEINE PHOSPHATE; PSEUDOEPHEDRINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: